Interview: The Chinese market is very open -potential -Bedi Nian, President of Nuohua Group (China)

Xinhua News Agency, Geneva, August 9th: The Chinese market is very open -potential -President Beide, President of Nuohua Group (China)

Xinhua News Agency reporter Chen Bin Jay Martina Fos

Beide, the president of the Novo Group (China), one of the world's top 500 companies, said in an exclusive video interview with Xinhua News Agency reporters that China is one of the most strategic markets in the world in the world. Business.

The Novartis Group, headquartered in Basel, Switzerland, is one of the world's largest pharmaceutical companies and currently has more than 8,000 employees in China.

Bedian said that from the source of the Nuohua Group's income, the Chinese market ranks third in the global market. In 2021, Nuohua Group (China) achieved a 19%performance growth. It is expected that by 2024, China will become the world's second largest market in the world.

Bedian believes that there are still many uns development potential and business opportunities in the Chinese market. Novartis focuses on providing high -quality innovative drugs for the Chinese market to meet the diversified needs of the Chinese market. In the next 5 years, Novartis plans to launch 50 new drugs, which is "very optimistic" in the prospects of China's innovation medicine industry.

When it comes to the impact of the new crown epidemic on Novo China ’s business, Beddian said that although the new crown epidemic has a impact on the global supply chain, Novartis’ s production and operation in China have not been seriously affected. He is satisfied with the current situation of Novartis in China and is optimistic about development prospects.

"From a policy point of view, China is very open. I think (Chinese government) is one of the most open governments I have encountered." He said.

[Editor in charge: Wang Xue]

- END -